Development and investigation of recombinant immunotoxin protein 4D5scFv-mCherry-PE(40)

O. N. Shilova, E. A. Souslova, A. M. Pilunov, S. M. Deyev, R. V. Petrov

Research output: Contribution to journalArticlepeer-review


Development of agents for theranostics implies combining the targeting module, the effector module, and the detection module within the same complex or recombinant protein. We have constructed, isolated, and characterized the 4D5scFv-mCherry-PE(40) protein, which exhibits fluorescent properties and specifically binds to cancer cells expressing the HER2 receptor and reduces their viability. The ability of the obtained targeted antitumor agent 4D5scFv-mCherry-PE(40) to selectively stain the HER2-positive cells and its highly selective cytotoxicity against these cells make the obtained targeted recombinant protein 4D5scFv-mCherry-PE(40) a promising theranostic agent for the diagnostics and therapy of HER2-positive human tumors.

Original languageEnglish
Pages (from-to)450-453
Number of pages4
JournalDoklady Biochemistry and Biophysics
Issue number1
Publication statusPublished - 1 Nov 2016
Externally publishedYes

ASJC Scopus subject areas

  • Biophysics
  • Chemistry(all)
  • Medicine(all)
  • Biochemistry

Fingerprint Dive into the research topics of 'Development and investigation of recombinant immunotoxin protein 4D5scFv-mCherry-PE(40)'. Together they form a unique fingerprint.

Cite this